Serial Number | 78378648 |
Word Mark | INNUREX |
Filing Date | Thursday, March 4, 2004 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, December 26, 2014 |
Registration Number | 3431115 |
Registration Date | Tuesday, May 20, 2008 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 8, 2005 |
Certificate of Correction for Registration | In the heading, delete class 42. Statement(s): Column 2, line 2, after "technologies" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 4, after "products" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 13 after "vascularisation" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" should be inserted. |
Certificate of Correction for Registration | In the statement, Page 2, Column 1, line 15, after "Vascularisation" and injuries of the nervous, system, all should be inserted. |
Goods and Services | Chemical and biochemical products for use in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic variations thereof, all for in vivo use in gene delivery technology and catalysts for gene delivery technology in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease |
Goods and Services | Gene therapy and prophylaxis products, pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; vector production technologies and neurogenomics products in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; Chemical products for use in medical science for the treatment of diseases of the eye, vascular and neo-vascularisition disorders, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation *and injuries of the nervous, system all* in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; pharmaceutical and biochemical preparations for the treatment of damaged nerves and spinal injuries and for the induction of nerve re-growth; medical instruments and apparatus for the administration of gene and antibody-based therapy and prophylactics, preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, December 26, 2014 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, December 26, 2014 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Oxford BioMedica plc |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Oxford OX4 4GA GB |
Party Name | Oxford BioMedica plc |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Oxford OX4 4GA GB |
Party Name | Oxford BioMedica plc |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Oxford OX4 4GA GB |
Event Date | Event Description |
Friday, December 26, 2014 | CANCELLED SEC. 8 (6-YR) |
Monday, June 1, 2009 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
Tuesday, January 6, 2009 | ASSIGNED TO PARALEGAL |
Wednesday, December 17, 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, December 17, 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, December 9, 2008 | TEAS SECTION 7 REQUEST RECEIVED |
Monday, September 15, 2008 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
Monday, September 15, 2008 | ASSIGNED TO PARALEGAL |
Tuesday, May 20, 2008 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, April 16, 2008 | TTAB RELEASE CASE TO TRADEMARKS |
Wednesday, April 16, 2008 | OPPOSITION TERMINATED NO. 999999 |
Wednesday, April 16, 2008 | OPPOSITION DISMISSED NO. 999999 |
Tuesday, March 4, 2008 | PAPER RECEIVED |
Thursday, March 9, 2006 | OPPOSITION INSTITUTED NO. 999999 |
Thursday, December 8, 2005 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, November 8, 2005 | PUBLISHED FOR OPPOSITION |
Wednesday, October 19, 2005 | NOTICE OF PUBLICATION |
Thursday, September 22, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, September 16, 2005 | ASSIGNED TO LIE |
Tuesday, September 13, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 13, 2005 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, September 13, 2005 | EXAMINERS AMENDMENT MAILED |
Tuesday, September 13, 2005 | EXAMINERS AMENDMENT -WRITTEN |
Friday, September 9, 2005 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Monday, August 22, 2005 | WITHDRAWN BEFORE PUBLICATION |
Tuesday, May 24, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, May 20, 2005 | ASSIGNED TO LIE |
Tuesday, May 17, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 23, 2005 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, March 16, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, March 16, 2005 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, September 22, 2004 | NON-FINAL ACTION MAILED |
Tuesday, September 21, 2004 | NON-FINAL ACTION WRITTEN |
Monday, September 20, 2004 | ASSIGNED TO EXAMINER |
Friday, March 19, 2004 | NEW APPLICATION ENTERED IN TRAM |